Macrophage-derived HB-EGF activates EGFR signaling to impair atherogenic macrophage–vascular smooth muscle cell crosstalk in ASCVD
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide. Despite advances in lipid-lowering therapies, substantial residual cardiovascular risk persists, highlighting the need to identify non-lipid-mediated mechanisms of disease susceptibility. Inflammation plays a central role...